-
Something wrong with this record ?
Depletion of alveolar macrophages attenuates hypoxic pulmonary hypertension but not hypoxia-induced increase in serum concentration of MCP-1
M. Žaloudíková, R. Vytášek, O. Vajnerová, O. Hniličková, M. Vízek, V. Hampl, J. Herget
Language English Country Czech Republic
Document type Journal Article
Grant support
NT13358
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Macrophages, Alveolar secretion MeSH
- Chemokine CCL2 blood MeSH
- Clodronic Acid therapeutic use MeSH
- Hypoxia complications MeSH
- Hypertension, Pulmonary immunology prevention & control MeSH
- Rats, Wistar MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Exposure to hypoxia, leading to hypoxic pulmonary hypertension (HPH), is associated with activation of alveolar macrophages (AM). However, it remains unclear how AM participate in this process. There are studies which imply that the AM product monocyte chemoattractant protein-1 (MCP-1) plays an important role. Thus we tested: 1. if the selective elimination of AM attenuates HPH in rats, 2. the correlation of MCP-1 plasmatic concentrations with the presence and absence of AM during exposure to hypoxia, 3. the direct influence of hypoxia on MCP-1 production in isolated AM. We found that experimental depletion of AM attenuated the chronic hypoxia-induced increase in mean pulmonary arterial pressure, but did not affect the serum MCP-1 concentrations. Furthermore, the MCP-1 production by AM in vitro was unaffected by hypoxia. Thus we conclude that AM play a significant role in the mechanism of HPH, but MCP-1 release from these cells is most likely not involved in this process. The increase of MCP-1 accompanying the development of HPH probably originates from other sources than AM.
Department of Pathophysiology 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Physiology 2nd Faculty of Medicine Charles University Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17012781
- 003
- CZ-PrNML
- 005
- 20190920125611.0
- 007
- ta
- 008
- 170412s2016 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933187 $2 doi
- 035 __
- $a (PubMed)27429111
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Žaloudíková, Marie, $u Department of Pathophysiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic $d 1971- $7 xx0206604
- 245 10
- $a Depletion of alveolar macrophages attenuates hypoxic pulmonary hypertension but not hypoxia-induced increase in serum concentration of MCP-1 / $c M. Žaloudíková, R. Vytášek, O. Vajnerová, O. Hniličková, M. Vízek, V. Hampl, J. Herget
- 520 9_
- $a Exposure to hypoxia, leading to hypoxic pulmonary hypertension (HPH), is associated with activation of alveolar macrophages (AM). However, it remains unclear how AM participate in this process. There are studies which imply that the AM product monocyte chemoattractant protein-1 (MCP-1) plays an important role. Thus we tested: 1. if the selective elimination of AM attenuates HPH in rats, 2. the correlation of MCP-1 plasmatic concentrations with the presence and absence of AM during exposure to hypoxia, 3. the direct influence of hypoxia on MCP-1 production in isolated AM. We found that experimental depletion of AM attenuated the chronic hypoxia-induced increase in mean pulmonary arterial pressure, but did not affect the serum MCP-1 concentrations. Furthermore, the MCP-1 production by AM in vitro was unaffected by hypoxia. Thus we conclude that AM play a significant role in the mechanism of HPH, but MCP-1 release from these cells is most likely not involved in this process. The increase of MCP-1 accompanying the development of HPH probably originates from other sources than AM.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a chemokin CCL2 $x krev $7 D018932
- 650 _2
- $a dichlormethylendifosfonát $x terapeutické užití $7 D004002
- 650 _2
- $a plicní hypertenze $x imunologie $x prevence a kontrola $7 D006976
- 650 _2
- $a hypoxie $x komplikace $7 D000860
- 650 _2
- $a alveolární makrofágy $x sekrece $7 D016676
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a potkani Wistar $7 D017208
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vytášek, Richard $7 xx0106988 $u Department of Pathophysiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Vajnerová, Olga $7 xx0036859 $u Department of Physiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Hniličková, Olga $7 xx0077558 $u Department of Physiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Vízek, Martin, $d 1943- $7 jn20000402660 $u Department of Pathophysiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Hampl, Václav, $d 1962- $7 nlk20030127352 $u Department of Physiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Herget, Jan, $d 1945-2019 $7 nlk19990073223 $u Department of Physiology, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 65, č. 5 (2016), s. 763-768
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20170412 $b ABA008
- 991 __
- $a 20190920130003 $b ABA008
- 999 __
- $a ok $b bmc $g 1201959 $s 973554
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 65 $c 5 $d 763-768 $e 20160715 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- GRA __
- $a NT13358 $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20170412